These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38032355)

  • 1. Clinical and Immunologic Features of Germline Pathogenic Variant-Positive Patients with Melanoma.
    Shen A; Arbesman M; Lodha R; Rayman P; Bungo B; Ni Y; Chan T; Gastman B; Ko J; Diaz-Montero CM; Arbesman J; Funchain P
    Clin Cancer Res; 2024 Feb; 30(3):564-574. PubMed ID: 38032355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive analysis of germline predisposition to early-onset ovarian cancer.
    Horackova K; Zemankova P; Nehasil P; Vocka M; Hovhannisyan M; Matejkova K; Janatova M; Cerna M; Kleiblova P; Jelinkova S; Stastna B; Just P; Dolezalova T; Nemcova B; Urbanova M; Koudova M; Hazova J; Machackova E; Foretova L; Stranecky V; Zikan M; Kleibl Z; Soukupova J
    Sci Rep; 2024 Jul; 14(1):16183. PubMed ID: 39003285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients.
    Aoude LG; Bonazzi VF; Brosda S; Patel K; Koufariotis LT; Oey H; Nones K; Wood S; Pearson JV; Lonie JM; Arneil M; Atkinson V; Smithers BM; Waddell N; Barbour AP
    Sci Rep; 2020 Oct; 10(1):17687. PubMed ID: 33077847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
    Tian Q; Gao H; Zhao W; Zhou Y; Yang J
    Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vulvar Melanoma in association with germline MITF p.E318K variant.
    Koeller DR; Schwartz A; DeSimone MS; Rana HQ; Rojas-Rudilla V; Russell-Goldman E; Laga AC; Lindeman NI; Garber JE; Ghazani AA
    Cancer Genet; 2022 Apr; 262-263():102-106. PubMed ID: 35220194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Japanese case of familial malignant melanoma with germline CDK4 variant incidentally diagnosed by cancer genome profiling.
    Kiyozumi Y; Goto K; Yoshikawa S; Kiyohara Y; Tsushima T; Kado N; Nishimura S; Higashigawa S; Harada R; Kunitomo K; Fukuzaki N; Matsubayashi H
    J Hum Genet; 2023 May; 68(5):359-361. PubMed ID: 36631500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.
    Njauw CN; Kim I; Piris A; Gabree M; Taylor M; Lane AM; DeAngelis MM; Gragoudas E; Duncan LM; Tsao H
    PLoS One; 2012; 7(4):e35295. PubMed ID: 22545102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family Recall of and Response to Germline Pathologic Variants Found on Paired Tumor-Germline Sequencing in Pediatric Oncology.
    Jacobs MF; Goldman JW; Austin S; Koeppe ES; Murad AM; Koschmann CJ; Chinnaiyan AM; Mody RJ
    JCO Precis Oncol; 2024 Mar; 8():e2300539. PubMed ID: 38484211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative lactylation and tumor microenvironment signature as prognostic and therapeutic biomarkers in skin cutaneous melanoma.
    Zhu Y; Song B; Yang Z; Peng Y; Cui Z; Chen L; Song B
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17897-17919. PubMed ID: 37955686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated case-control and somatic-germline interaction analyses of melanoma susceptibility genes.
    Yu Y; Hu H; Chen JS; Hu F; Fowler J; Scheet P; Zhao H; Huff CD
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2247-2254. PubMed ID: 29317335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
    Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
    PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. POLE mutations in families predisposed to cutaneous melanoma.
    Aoude LG; Heitzer E; Johansson P; Gartside M; Wadt K; Pritchard AL; Palmer JM; Symmons J; Gerdes AM; Montgomery GW; Martin NG; Tomlinson I; Kearsey S; Hayward NK
    Fam Cancer; 2015 Dec; 14(4):621-8. PubMed ID: 26251183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.
    Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L
    Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
    Liu X; Wang J
    Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary cancer predispositions: Comparison of multigene panel sequencing on fresh-frozen breast/ovarian tumor versus blood.
    Schwartz M; Moncoutier V; Peytral A; Le Gall J; Suybeng V; Pagès M; Masliah-Planchon J; Trabelsi-Grati O; Melaabi S; Callens C; Bièche I; Delhomelle H; De Pauw A; Saule C; Mouret-Fourme E; Gauthier-Villars M; Buecher B; Colas C; Stoppa-Lyonnet D; Golmard L
    Clin Genet; 2023 Jul; 104(1):107-113. PubMed ID: 36974006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients.
    Dalmasso B; Pastorino L; Ciccarese G; Andreotti V; Grillo F; Mastracci L; Spagnolo F; Ballestrero A; Queirolo P; Bruno W; Ghiorzo P
    J Am Acad Dermatol; 2019 May; 80(5):1263-1271. PubMed ID: 30274933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of TME-related signatures to predict prognosis and response to anti-tumor therapies in skin cutaneous melanoma.
    Lian W; Zheng X
    Funct Integr Genomics; 2023 May; 23(2):153. PubMed ID: 37160578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.
    Pritchard AL; Johansson PA; Nathan V; Howlie M; Symmons J; Palmer JM; Hayward NK
    PLoS One; 2018; 13(4):e0194098. PubMed ID: 29641532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor receptor family mutations as a predictive biomarker for immune checkpoint inhibitors and its correlation with tumor immune microenvironment in melanoma.
    Zhang W; Xia H; Yang R; Zhang Y; Zheng Q; Shang X; Liu N; Ma X; Wei C; Chen H; Mu X; Wang X; Liu Y
    Front Immunol; 2022; 13():1030969. PubMed ID: 36426352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of differential gene immune infiltration and clinical characteristics of skin cutaneous melanoma based on systems biology and drug repositioning methods to identify drug candidates for skin cutaneous melanoma.
    Long S; Xu J; Huang H
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2427-2447. PubMed ID: 37086280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.